Afya Limited Unsponsored BDR A (A2FY34) Stock Price & Analysis

A2FY34 Stock Chart & Stats

R$28.80R$2.00(7.46%)

At close: Nov 03

Day’s Range: BRL 28.44 - BRL 28.86
52-Week Range: BRL 24.25 - BRL 46.00
Previous Close: BRL 26.80
Volume: N/A
Average Volume (3M): 10.97K
Market Cap: BRL 5.34B
Enterprise Value: BRL 9.22B
Total Cash (Recent Filing): N/A
Total Debt (Recent Filing): N/A
Price to Earnings (P/E): 6.1
Beta: 0.63
Next Earnings: Nov 12, 2026 (Est.)
EPS Estimate: N/A
Next Dividend Ex-Date: N/A
Dividend Yield: 6.16%

Afya Limited Unsponsored BDR A News

Afya price target lowered to $17.50 from $19 at JPMorgan

JPMorgan analyst Marcelo Santos lowered the firm’s price target on Afya (AFYA) to $17.50 from $19 and keeps an Overweight rating on the shares. The firm updated estimates in the

1d agoAFYA 1AY

Afya upgraded to Buy at Citi amid ‘resilient undergraduate trends’

As previously reported, Citi upgraded Afya (AFYA) to Buy from Neutral with a price target of $12, down from $16. The firm expects the company to report a good quarter

1d agoAFYA 1AY

Afya upgraded to Buy from Neutral at Citi

Citi upgraded Afya (AFYA) to Buy from Neutral with a price target of $12, down from $16. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial

2d agoAFYA 1AY

BofA upgrades Afya to Buy after ‘exaggerated’ sellofff

As previously reported, BofA upgraded Afya (AFYA) to Buy from Neutral with a price target of $16, down from $19. The recent selloff was “exaggerated” considering Afya’s exposure to a

6d agoAFYA 1AY

Afya upgraded to Buy from Neutral at BofA

BofA analyst Flavio Yoshida upgraded Afya (AFYA) to Buy from Neutral with a price target of $16, down from $19. Published first on TheFly – the ultimate source for real-time,

6d agoAFYA 1AY

Afya: Strategic Upside Priced In as Integration and Segment Underperformance Risks Drive Sell Rating

Analyst Mauricio Cepeda of Morgan Stanley maintained a Sell rating on Afya, with a price target of $15.00. Mauricio Cepeda has given his Sell rating due to a combination of

2w agoAFYA 1AY

Afya upgraded to Overweight from Neutral at JPMorgan

JPMorgan analyst Marcelo Santos upgraded Afya (AFYA) to Overweight from Neutral with a price target of $19, down from $21. The firm is constructive on the company’s merger with Yduqs.

4w agoAFYA 1AY

Afya upgraded to Outperform from Underperform at Bradesco BBI

Bradesco BBI upgraded Afya (AFYA) to Outperform from Underperform with a $17 price target Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

1M agoAFYA 1AY

Afya announces medical seats increase in AFYA Cruzeiro de Sul

Afya (AFYA) announced that the Secretary of Regulation and Supervision of Higher Education of the Ministry of Education authorized the increase of 17 medical seats of ITPAC Cruzeiro do Sul

1M agoAFYA 1AY

Afya comments on disclosure by Yduqs regarding potential business combination

Afya (AFYA) Limited announced that discussions with Yduqs Participacoes regarding a potential business combination involving the two companies are at an early stage, following the material fact disclosed by Yduqs

2M agoAFYA 1AY

Afya reports Q2 EPS R$2.22 vs. R$1.90 last year

Reports Q2 revenue R$972.1M vs. $919.4M last year. Q2 revenue excluding acquisitions increased 5.4% to R$969.3M. Afya (AFYA) management commented, “During the first half of 2026, Afya continued to execute

2M agoAFYA 1AY

A2FY34 FAQ

What was Afya Limited Unsponsored BDR A’s price range in the past 12 months?

Afya Limited Unsponsored BDR A lowest stock price was R$24.25 and its highest was R$46.00 in the past 12 months.

What is Afya Limited Unsponsored BDR A’s market cap?

Afya Limited Unsponsored BDR A’s market cap is R$5.34B.

When is Afya Limited Unsponsored BDR A’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

How were Afya Limited Unsponsored BDR A’s earnings last quarter?

Afya Limited Unsponsored BDR A released its earnings results on Aug 13, 2026. The company reported R$1.109 earnings per share for the quarter.

Is Afya Limited Unsponsored BDR A overvalued?

Not enough analysts have published a price target to calculate whether the price is overvalued.

Does Afya Limited Unsponsored BDR A pay dividends?

Afya Limited Unsponsored BDR A does not currently pay dividends.

What is Afya Limited Unsponsored BDR A’s EPS estimate?

Afya Limited Unsponsored BDR A’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Afya Limited Unsponsored BDR A have?

Afya Limited Unsponsored BDR A has 105,756,980 shares outstanding.

What happened to Afya Limited Unsponsored BDR A’s price movement after its last earnings report?

Afya Limited Unsponsored BDR A reported an EPS of R$1.109 in its last earnings report. Following the earnings report the stock price went down -1.724%.

Which hedge fund is a major shareholder of Afya Limited Unsponsored BDR A?

Currently, no hedge funds are holding shares in BR:A2FY34

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Afya Limited Unsponsored BDR A (A2FY34) Earnings & Revenues

Historic Earnings Reports

Technical Analysis

Overall Consensus

Indicator	Bullish	Neutral	Bearish
Overall Consensus	4	6	12
Technical Analysis	2	6	2
Moving Averages	2	0	10

Technical Analysis >

Similar Stocks

Stocks similar to BR:A2FY34
Company	Price & Change	Follow
BR:C2OU34Coursera Inc Shs Unsponsored Brazilian Depositary Receipt Repr 0.5 Sh
BR:DASA3Diagnosticos da America S.A.
BR:HAPV3Hapvida Participacoes e Investimentos SA
BR:COGN3Cogna Educacao S.A.
BR:FLRY3Fleury SA

Compare BR:A2FY34 Stocks >

Popular Stocks

Popular Stocks
Company	Price & Change	Follow
NVDANvidia
AAPLApple
MSFTMicrosoft